These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2529873)

  • 21. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis.
    Wendel GD; Cox SM; Bawdon RE; Theriot SK; Heard MC; Nobles BJ
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 2):1390-6. PubMed ID: 2031520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ampicillin-sulbactam versus cefoxitin for prophylaxis in high-risk patients undergoing abdominal surgery.
    Paladino JA; Rainstein MA; Serrianne DJ; Przylucki JE; Welage LS; Collura ML; Schentag JJ
    Pharmacotherapy; 1994; 14(6):734-9. PubMed ID: 7885978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second look laparoscopy; evaluation of two different antibiotic regimens after treatment of acute salpingitis.
    Brihmer C; Kallings I; Nord CE; Brundin J
    Eur J Obstet Gynecol Reprod Biol; 1989 Mar; 30(3):263-74. PubMed ID: 2523827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.
    Akova M; Ozcebe O; Güllü I; Unal S; Gür D; Akalin S; Tokgözoglu M; Telatar F; Akalin HE
    J Chemother; 1996 Aug; 8(4):284-9. PubMed ID: 8873834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
    Talan DA; Summanen PH; Finegold SM
    Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New specialty drugs registered in Austria. Unasyn].
    Ganzinger U
    Wien Klin Wochenschr; 1989 Nov; 101(21):754-60. PubMed ID: 2686180
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
    Azimi PH; Barson WJ; Janner D; Swanson R
    Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical and bacteriological efficacy of the combined preparation ampicillin/sulbactam (Unasyn) in treating different infections].
    Strachunskiĭ LS; Novikova IuA; Prokhorenkov PI; Iakusheva LV
    Antibiot Khimioter; 1991 Jun; 36(6):18-21. PubMed ID: 1898183
    [No Abstract]   [Full Text] [Related]  

  • 29. Infectious complications after 809 biliary tract operations and results of a prospective randomized single-blind study comparing cefoxitin versus ampicillin plus an inhibitor of beta-lactamases.
    Wittmann DH; Koltowski P; Oleszkiewicz J; Walker AP
    Infection; 1990; 18(1):41-7. PubMed ID: 2179137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
    Dajani A
    J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second look laparoscopy after treatment of acute salpingitis with doxycycline/benzylpenicillin procaine or trimethoprim-sulfamethoxazole.
    Brihmer C; Brundin J
    Scand J Infect Dis Suppl; 1988; 53():65-9. PubMed ID: 2971268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic prophylaxis in cardiovascular surgery: comparison of sulbactam-ampicillin and cefuroxime].
    Girotto M; Comoglio C; Donegani E; Di Summa M
    Riv Eur Sci Med Farmacol; 1993; 15(1):43-6. PubMed ID: 8159835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion of treatment from cefoxitin to ampicillin/sulbactam: experience in a university teaching hospital.
    Kitrenos JG; Rotella DL; Nakasato S
    Adv Ther; 1995; 12(1):30-43. PubMed ID: 10150321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly.
    Okimoto N; Kurihara T; Honda N; Asaoka N; Fujita K; Ohba H; Nakamura J
    J Infect Chemother; 2003 Jun; 9(2):183-6. PubMed ID: 12825120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Laparoscopic control in the treatment of salpingitis. Apropos of 40 cases].
    Lenck LC; Fallouh B; Labouz F; Jacquetin B
    Rev Fr Gynecol Obstet; 1988 Jun; 83(6):401-5. PubMed ID: 2970110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
    Chan JC
    Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
    Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
    Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of bacterial infections with sultamicillin in childhood].
    Scholz H; Märker X; Rockstroh T
    Z Arztl Fortbild (Jena); 1991 Jul; 85(13):610-4. PubMed ID: 1949980
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.
    Rice LB; Carias LL; Shlaes DM
    Antimicrob Agents Chemother; 1993 Mar; 37(3):610-2. PubMed ID: 8460928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.